Labshake search
Citations for R&D Systems :
2951 - 3000 of 3610 citations for Testosterone D5 98% 100 Ug Ml In Dioxane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: ... as well as ESAT-6 tetramer (as above) presence of 1μg/ml Cyclosporine A (R&D Systems) to prevent tetramer-mediated activation of T cells ...
-
bioRxiv - Immunology 2020Quote: ... over 7 days followed by 18 h treatment with IFN-γ (20 ng/ml; R&D Systems) plus LPS (100 ng/ml ...
-
bioRxiv - Cancer Biology 2020Quote: ... Supernatant samples (1 ml) and a Proteome Profiler Mouse XL Cytokine Array Kit (#ARY028, R&D Systems) were used according to the manufacturer’s instructions ...
-
bioRxiv - Immunology 2021Quote: ... cells were stained with a primary antibody against ACE2 (4µg/ml, R&D Systems, catalog no. AF933) followed by a secondary antibody labelled with Alexa Fluor 568 (1:1000 ...
-
bioRxiv - Developmental Biology 2021Quote: ... Media was changed every 2 days using differentiation media supplemented with 100ng/ml VEGF (R&D Systems) and 50ng/ml bFGF (R&D Systems) ...
-
bioRxiv - Cell Biology 2021Quote: ... and immunostained with 0.5 μg/ml mouse monoclonal anti-MHC antibody (MF20; R&D Systems, MN, USA) and 1.0 μg/ml rabbit polyclonal anti-nucleolin antibody (ab22758 ...
-
bioRxiv - Immunology 2020Quote: ... Collected ILCs were rested in 10ng/mL IL-2 and IL-7 (R&D Systems, Minneapolis, MN) in T-cell media (TCM ...
-
bioRxiv - Genetics 2020Quote: ... sections were incubated with 5 μg/ml goat anti-mouse CD31 (R&D Systems, Inc, Minneapolis, MN) overnight at 4°C ...
-
bioRxiv - Molecular Biology 2022Quote: ... 10 ng/ml recombinant human brain-derived neurotrophic factor (BDNF) protein (R&D Systems 248-BDB-005), and 10 µM ɣ-secretase inhibitor (DAPT ...
-
bioRxiv - Cell Biology 2022Quote: ... Cells were then treated with 10 ng/ml of recombinant human EGF (236-EG, R&D systems) in RPMI-1640 medium and incubated at 37℃ ...
-
The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signalingbioRxiv - Cell Biology 2022Quote: ... then treated with 20-25 ng/ml recombinant human BMP4 protein (R&D Systems, Cat# 314-BP). For acetylcholine receptor clustering experiments ...
-
bioRxiv - Developmental Biology 2022Quote: ... Embryos were treated with 150 ng/ml of recombinant mouse BMP2 protein (355-BEC, R&D Systems Inc ...
-
bioRxiv - Neuroscience 2022Quote: ... and 25 ng/ml (422.6 nM) Hyper-IL-6 (R&D Systems, Cat. no. 8954-SR-025) at day 45 of differentiation ...
-
bioRxiv - Neuroscience 2022Quote: ... containing medium supplemented with BDNF (20 ng/ml; catalog#248-BDB, R&D Systems, Minneapolis, MN, USA), cAMP (0.5 mM ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant Human IL-27 Ra/WSX-1/TCCR Fc Chimera Protein (2 μg/ml, R&D Systems), Ultrapure LPS from E ...
-
bioRxiv - Cell Biology 2024Quote: ... and 125 ng/mL Fibroblast growth factor (FGF) -8b (423-F8-025/CF; R&D Systems Inc) to DPSC-BM as previously reported [35] ...
-
bioRxiv - Cancer Biology 2024Quote: ... Cells were stimulated with recombinant mouse VEGF-A (300 ng/mL, R&D Systems #493-MV-005), recombinant mouse VEGF-B186 (300 ng/mL) ...
-
bioRxiv - Bioengineering 2024Quote: ... which was supplemented with 3 ng/mL human activin A (R&D Systems, Inc., Minneapolis, MN, USA), 1 ng/mL human bone morphogenetic protein 4 (Bmp4 ...
-
bioRxiv - Cancer Biology 2024Quote: ... or differentiation medium with tamoxifen and 10µg/mL of soluble fibronectin protein (R&D systems, 1918-FN). Images were analyzed using QuPath v0.4.0 (52).
-
An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangiomabioRxiv - Molecular Biology 2024Quote: ... The medium was replaced with fresh differentiation medium containing 10 ng/mL VEGF-B (R&D Systems) every two days ...
-
bioRxiv - Cell Biology 2023Quote: ... following 5 min of stimulation with 10 ng/ml PDGF-BB (R&D Systems, Minneapolis, MN, USA) in the case of the PDGFRαV1/βV2 heterodimer cell line ...
-
bioRxiv - Immunology 2024Quote: ... dFBs were treated with either recombinant mouse IFNγ (5 ng/ml, R&D Systems, Minneapolis, MN, USA) for 8 or 24 hours before being subjected to qRT-PCR or ELISA analysis.
-
bioRxiv - Cell Biology 2023Quote: ... the pro- and undifferentiated spermatogonia marker PLZF (day 5-35; 0.6 µg/ml, R&D Systems AF2944), and dual stained with the transcription factor marker FOXO1 (day 7 ...
-
bioRxiv - Neuroscience 2023Quote: ... coated 6 well plates in oRIM supplemented with 2.6 nM (20 ng/mL) IGF1 (R&D Systems). On day 24 ...
-
bioRxiv - Microbiology 2023Quote: ... Uninfected cells were treated with DPBS or 1000U/ml of Universal Type 1 Interferon (R&D Systems) for 30 minutes ...
-
bioRxiv - Molecular Biology 2022Quote: ... cells were stimulated overnight with 5 pg/ml of BMP9 in serum-free medium (R&D Systems) and luciferase activity was measured with the twinlite Firefly and Renilla Luciferase Reporter Gene Assay System (PerkinElmer) ...
-
bioRxiv - Neuroscience 2023Quote: ... medium was replaced with EB medium supplemented with Sonic Hedgehog (SHH; 20 ng/mL, R&D Systems) and fibroblast growth factor 8 (FGF8 ...
-
bioRxiv - Genetics 2023Quote: ... and receptor activator of nuclear factor kappa-B ligand (RANKL) (2 ng/mL; R&D systems; USA) to induce osteoclastogenesis ...
-
bioRxiv - Molecular Biology 2023Quote: ... the following antibodies were used: anti-MMP-2 (AF902, 2 μg/ml; R&D Systems, Abington, UK); anti-MMP-9 (MAB-911 ...
-
bioRxiv - Bioengineering 2023Quote: ... or mouse anti-β-III tubulin antibody (cat. MAB1195 R&D systems, 10ug/ml in 1X PBS) overnight at 4°C ...
-
bioRxiv - Microbiology 2023Quote: ... to promote M1-differentiation or 20 ng/ml macrophage colony-stimulating factor (M-CSF; R&D Systems) to promote M2-differentiation as previously described [9] ...
-
bioRxiv - Cancer Biology 2023Quote: ... and prepared for GPC6 staining (goat anti-mouse Gpc6, 10µg/mL, R&D Systems, cn: AF1053, ln:GJA0219031) through the following treatment ...
-
bioRxiv - Cell Biology 2023Quote: ... TGF-β pathway was stimulated by adding rhTGF-β1 ligand (2ng/mL; R&D Systems; 240-B) for 24 hours ...
-
bioRxiv - Biochemistry 2023Quote: ... 20 ng/mL recombinant mouse tumor necrosis factor-α (TNF-α) (R&D Systems, 41-0MT0-25CF) and 12 ng/mL recombinant mouse IFN-γ were added to the media.
-
bioRxiv - Cancer Biology 2022Quote: ... unconditioned HEI-193 media supplemented with recombinant human CCL21 600 ng/ml (366-6C, R&D Systems) as a positive control ...
-
bioRxiv - Immunology 2023Quote: ... stimulation medium (2X concentration) was prepared by adding 400 ng/mL HA-tagged rhCD40L (R&D Systems) and 100 ng/mL anti-HA tag antibody (clone 543851 ...
-
bioRxiv - Immunology 2023Quote: ELISA plates were coated with 2 µg/ml mouse anti-His tag antibody (R&D Systems, MAB050) and blocked as described above ...
-
bioRxiv - Developmental Biology 2023Quote: ... 10μM of compound E or 4μg/ml of recombinant Fc-JAG1 (R&D Systems, Cat #599-JG). After the EU labelling ...
-
bioRxiv - Molecular Biology 2023Quote: ... goat anti-mouse IL-1β polyclonal antibody (250 ng ml−1; R&D Systems, AF-401-NA) rabbit anti-mouse caspase-1 + p10 + p12 monoclonal antibody (1.87 µg ml−1 ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (50 ng/mL) (R&D Systems) and recombinant human interleukin-4 (IL-4 ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed every day to HDM with 20 ng/mL human recombinant HGF (R&D Systems). After 14 to 24 days ...
-
bioRxiv - Microbiology 2023Quote: ... Monocyte-derived macrophages were differentiated from primary monocytes by 50 ng/ml GM-CSF (R&D Systems) treatment for 6-10 days ...
-
bioRxiv - Cell Biology 2024Quote: ... Recombinant human vascular endothelial growth factor-C (VEGF-C) (R&D Systems; #9199-VC; 7.5 ng/mL) was also added to the MV2 full growth medium ...
-
bioRxiv - Neuroscience 2024Quote: ... media was replaced fully with NIM with 10 ng/mL BMP4 (R&D Systems #314-BP-050). On day N5 ...
-
bioRxiv - Bioengineering 2024Quote: ... Hepes and penicillin-streptomycin supplemented with epidermal growth factor (EGF, “E,” 50 ng/mL, R&D Systems), Noggin (“N,” 100 ng/mL ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... there were six mice per treatment and control group for a total of 78 mice in thirteen groups: (A) Seven vaccine groups included 1 μg of unformulated SARS-CoV-2 spike protein (R&D Systems, Cat# 10549-CV-100) delivered with adjuvanted NPs ...
-
bioRxiv - Cancer Biology 2023Quote: ... T cells were isolated and stained with anti- human CD3 and CD8a antibodies (surface staining) followed by intracellular staining with anti- human IFNγ (R&D Systems, Cat. No. IC285F-100) antibody ...
-
bioRxiv - Microbiology 2023Quote: ... This was followed by incubation of the cut membranes with primary antibody polyclonal goat anti-human EpCAM (R&D Systems, AF960, 1:100 in SEA BLOCK) overnight at 4°C in a humidified chamber ...
-
bioRxiv - Cell Biology 2020Quote: ... or cytokines mix IL-1β (50 U/mL) (cat. #201-LB-005 - R&D System, Minneapolis, MN, USA), TNFα (1000 U/mL ...
-
bioRxiv - Immunology 2021Quote: ... the membrane was incubated with mouse anti-human IL-22 antibody (1 μg/ml; R&D systems, USA) overnight at 4°C ...